title: Involvement of Src kinase in T-type calcium channel-dependent neuronal differentiation of NG108-15 cells by hydrogen sulfide.
abstract: Hydrogen sulfide (H(2)S), a gasotransmitter, induces neuronal differentiation characterized by neuritogenesis and functional up-regulation of high voltage-activated Ca(2+) channels, via activation of T-type Ca(2+) channels in NG108-15 cells. We thus analyzed signaling mechanisms for the H(2)S-evoked neuronal differentiation. NaHS, a donor for H(2)S, facilitated T-type Ca(2+) channel-dependent membrane currents, an effect blocked by ascorbic acid that selectively inhibits Ca(v)3.2 among three T-type channel isoforms. NaHS, applied once at a high concentration (13.5 mM) or repetitively at a relatively low concentration (1.5 mM), as well as ionomycin, a Ca(2+) ionophore, evoked neuritogenesis. The neuritogenesis induced by NaHS, but not by ionomycin, was abolished by mibefradil, a T-type Ca(2+) channel blocker. PP2, a Src kinase inhibitor, completely suppressed the neuritogenesis caused by NaHS or ionomycin, while it only partially blocked neuritogenesis caused by dibutyryl cAMP, a differentiation inducer. NaHS, but not dibutyryl cAMP, actually caused phosphorylation of Src, an effect blocked by 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl, an intracellular Ca(2+) chelator, mibefradil or ascorbic acid. The up-regulation of high voltage-activated currents in the cells treated with NaHS was also inhibited by PP2. Together, our data reveal that Src kinase participates in the T-type Ca(2+) channel-dependent neuronal differentiation caused by NaHS/H(2)S in NG108-15 cells.
authors.affiliation: Division of Pharmacology and Pathophysiology, Kinki University School of Pharmacy, Higashi-Osaka, Japan.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Tarui
authors.forename: Kazuki
authors.initials: K
authors.lastname: Fukami
authors.forename: Keita
authors.initials: K
authors.lastname: Nagasawa
authors.forename: Shigeru
authors.initials: S
authors.lastname: Yoshida
authors.forename: Fumiko
authors.initials: F
authors.lastname: Sekiguchi
authors.forename: Atsufumi
authors.initials: A
authors.lastname: Kawabata
mesh_terms: D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D020747:Calcium Channels, T-Type / Q000502:physiology*; D002454:Cell Differentiation; D045744:Cell Line, Tumor; D006822:Hybrid Cells; D006862:Hydrogen Sulfide / Q000378:metabolism*; D015640:Ion Channel Gating; D015759:Ionomycin / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D020748:Mibefradil / Q000494:pharmacology; D051379:Mice; D016501:Neurites / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000166:cytology*; D018408:Patch-Clamp Techniques; D010766:Phosphorylation; D051381:Rats; D013440:Sulfides / Q000494:pharmacology; D019061:src-Family Kinases / Q000502:physiology*
chemical_list: D002121:Calcium Channel Blockers; D020747:Calcium Channels, T-Type; D007476:Ionophores; D013440:Sulfides; D020748:Mibefradil; D015759:Ionomycin; D019061:src-Family Kinases; D001205:Ascorbic Acid; C033479:sodium sulfide; D006862:Hydrogen Sulfide